Vasundhara Rasy.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406F01010
  • NSEID:
  • BSEID: 538634
INR
178.10
3.8 (2.18%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 1.08 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Standalone Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 5.09% vs -8.18% in Mar 2025

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2026 is 36.24% vs -27.47% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 42.96% vs -36.62% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 48.15% vs 58.82% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2026 has improved from Mar 2025

Compare Annual Results Of Vasundhara Rasy. With
Markets Mojo
Figures in Cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
35.72
47.21
-11.49
-24.34%
Other Operating Income
0.00
0.00
0.00
Total Operating income
35.72
47.21
-11.49
-24.34%
Raw Material Cost
14.75
33.22
-18.47
-55.60%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.35
0.28
0.07
25.00%
Employee Cost
3.28
2.89
0.39
13.49%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
11.55
8.95
2.60
29.05%
Total Expenditure (Excl Depreciation)
29.93
45.34
-15.41
-33.99%
Operating Profit (PBDIT) excl Other Income
5.79
1.87
3.92
209.63%
Other Income
2.90
0.96
1.94
202.08%
Operating Profit (PBDIT)
8.69
2.83
5.86
207.07%
Interest
0.40
0.22
0.18
81.82%
Exceptional Items
0.00
18.99
-18.99
-100.00%
Gross Profit (PBDT)
8.29
21.60
-13.31
-61.62%
Depreciation
0.43
0.21
0.22
104.76%
Profit Before Tax
7.86
21.39
-13.53
-63.25%
Tax
2.07
3.82
-1.75
-45.81%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
5.79
17.57
-11.78
-67.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
5.79
17.57
-11.78
-67.05%
Equity Capital
3.18
6.83
-3.65
-53.44%
Face Value
10.00
10.00
0.00
Reserves
37.70
15.27
22.43
146.89%
Earnings per share (EPS)
18.21
25.72
-7.51
-29.20%
Diluted Earnings per share
18.22
25.74
-7.52
-29.22%
Operating Profit Margin (Excl OI)
16.21%
3.96%
0.00
12.25%
Gross Profit Margin
23.21%
45.75%
0.00
-22.54%
PAT Margin
16.21%
37.22%
0.00
-21.01%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 35.72 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 5.09% vs -8.18% in Mar 2025

Annual - Standalone Net Profit
Standalone Net Profit 5.79 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 36.24% vs -27.47% in Mar 2025

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 5.79 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 42.96% vs -36.62% in Mar 2025

Annual - Interest
Interest 0.40 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 48.15% vs 58.82% in Mar 2025

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.21%
in Mar 2026

Figures in %
stock-summary

YoY Growth in year ended Mar 2026 has improved from Mar 2025